SCHEMBL7044307

SCHEMBL7044307

O=Cc1ccccc1OCC1CO1.c1cc2ccc1CO2

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 8/20 0.48
GLA P06280 1/20 0.48
SMN1; SMN2 Q16637 2/20 0.46
HPGD P15428 1/20 0.46
HTT P42858 1/20 0.46
TDP1 Q9NUW8 2/20 0.41
PTGDR2 Q9Y5Y4 1/20 0.40
KMT2A Q03164 5/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
TP53 P04637 1/20 0.37
CYP3A4 P08684 1/20 0.37
TSHR P16473 1/20 0.37
HIF1A Q16665 1/20 0.37
SRC P12931 2/20 0.37
MEN1 O00255 3/20 0.36
MAPT P10636 1/20 0.35
LMNA P02545 2/20 0.35
GAA P10253 2/20 0.35
PKM P14618 1/20 0.34
KDM4E B2RXH2 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1034135 0.88 ALDH1A1 (0.60) ALDH1A1GLASMN1; SMN2HPGDHTT
SCHEMBL4367638 0.88 ALDH1A1 (0.60) ALDH1A1GLASMN1; SMN2HPGDHTT
SCHEMBL28937430 0.88 ALDH1A1 (0.60) ALDH1A1GLASMN1; SMN2HPGDHTT
SCHEMBL15074978 0.74 ALDH1A1 (0.50) ALDH1A1GLASMN1; SMN2HPGDHTT
2-Methoxybenzaldehyde SCHEMBL28826415 0.74 ALDH1A1 (0.45) ALDH1A1SMN1; SMN2HPGDHTTKMT2A
SCHEMBL8067869 0.73 ALDH1A1 (0.65) ALDH1A1GLASMN1; SMN2HPGDHTT
SCHEMBL1021608 0.73 ALDH1A1 (0.60) ALDH1A1GLASMN1; SMN2HPGDHTT
SCHEMBL5435175 0.73 ALDH1A1 (0.51) ALDH1A1GLASMN1; SMN2HPGDHTT
SCHEMBL29481798 0.72 ALDH1A1 (0.47) ALDH1A1GLASMN1; SMN2HPGDHTT
SCHEMBL19776394 0.72 ALDH1A1 (0.47) ALDH1A1GLASMN1; SMN2HPGDHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20030073846-A1 Aminoalcohol derivatives FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2003-04-17 US disclosed
EP-1292564-A2 AMINOALCOHOL DERIVATIVES FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2003-03-19 EP disclosed
WO-2001062705-A2 AMINOALCOHOL DERIVATIVES FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2001-08-30 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030073846-A1 Aminoalcohol derivatives XDH, ADH1A, ADRB1 ALDH1A1 103/4885GLA 3389/4885SMN1; SMN2 1487/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.